Clinical Trial Update: Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating add-on low-dose fenfluramine in Lennox-Gastaut epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• Fenfluramine (fenfluramine)

Snippet

Sponsor: KU Leuven | Conditions: Epilepsy, Lennox Gastaut Syndrome | Phase 2 | Status: UNKNOWN